CY1109876T1 - Μεθοδοι για εκλεκτικη στοχευση - Google Patents

Μεθοδοι για εκλεκτικη στοχευση

Info

Publication number
CY1109876T1
CY1109876T1 CY20101100233T CY101100233T CY1109876T1 CY 1109876 T1 CY1109876 T1 CY 1109876T1 CY 20101100233 T CY20101100233 T CY 20101100233T CY 101100233 T CY101100233 T CY 101100233T CY 1109876 T1 CY1109876 T1 CY 1109876T1
Authority
CY
Cyprus
Prior art keywords
target
ligands
bound
bind
ligand complex
Prior art date
Application number
CY20101100233T
Other languages
English (en)
Inventor
David A Estell
Christopher J Murray
Pilar Tijerina
Yiyou Chen
Original Assignee
Genencor International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International, Inc. filed Critical Genencor International, Inc.
Publication of CY1109876T1 publication Critical patent/CY1109876T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Abstract

Μια μέθοδος εκλεκτικής στόχευσης γνωστοποιείται η οποία περιλαμβάνει την επαφή μιας βιβλιοθήκης συνδετών, ειδικότερα μιας πεπτιδικής βιβλιοθήκης, με έναν αντι-στόχο για να καταστεί δυνατή η δέσμευση των συνδετών στον αντι-στόχο το διαχωρισμό των μη-δεσμευμένων συνδετών από τους δεσμευμένους στον αντι-στόχο συνδέτες, την επαφή των μη-δεσμευμένων σε αντι-στόχο συνδετών με έναν στόχο καθιστώντας δυνατή τη δέσμευση των μη-δεσμευμένων συνδετών με τον στόχο για σχηματισμό ενός συμπλόκου δεσμευμένου σε στόχο συνδέτη το διαχωρισμό του συμπλόκου δεσμευμένου σε στόχο συνδέτη από συνδέτες οι οποίοι δεν δεσμεύονται στον στόχο, και την ταυτοποίηση των δεσμευμένων σε στόχο συνδετών στο σύμπλοκο δεσμευμένου σε στόχο συνδέτη όπου οι δεσμευμένοι σε στόχο συνδέτες έχουν μια KD μέσα στο εύρος από περίπου 10-7 έως 10-10 Μ. Επιπροσθέτως αξιώνονται οι συνδέτες οι οποίοι ταυτοποιούνται σύμφωνα με τη μέθοδο.
CY20101100233T 2000-04-14 2010-03-10 Μεθοδοι για εκλεκτικη στοχευση CY1109876T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19725900P 2000-04-14 2000-04-14
EP01930480A EP1360500B1 (en) 2000-04-14 2001-04-11 Methods for selective targeting

Publications (1)

Publication Number Publication Date
CY1109876T1 true CY1109876T1 (el) 2014-09-10

Family

ID=22728668

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100233T CY1109876T1 (el) 2000-04-14 2010-03-10 Μεθοδοι για εκλεκτικη στοχευση

Country Status (12)

Country Link
US (5) US20020098524A1 (el)
EP (1) EP1360500B1 (el)
JP (2) JP4966470B2 (el)
AT (1) ATE455304T1 (el)
AU (1) AU2001257012A1 (el)
CA (1) CA2405715C (el)
CY (1) CY1109876T1 (el)
DE (1) DE60141088D1 (el)
DK (1) DK1360500T3 (el)
ES (1) ES2338097T3 (el)
PT (1) PT1360500E (el)
WO (1) WO2001079479A2 (el)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020098524A1 (en) 2000-04-14 2002-07-25 Murray Christopher J. Methods for selective targeting
US7129326B2 (en) * 2000-04-14 2006-10-31 Genencor International, Inc. Methods for selective targeting
AU2002230890A1 (en) * 2000-12-14 2002-06-24 Genencor International, Inc. Targeted enzyme prodrug therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
CA2513044A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
CA2502304C (en) * 2002-10-08 2013-10-01 Genencor International, Inc. Phenolic binding peptides
CN1774232B (zh) * 2002-11-25 2012-05-09 金克克国际有限公司 皮肤或毛发结合肽
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US20050226839A1 (en) * 2003-09-08 2005-10-13 Xueying Huang Pepetide-based body surface reagents for personal care
US7285264B2 (en) 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US20100311641A1 (en) * 2003-09-08 2010-12-09 E. I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US20050054752A1 (en) * 2003-09-08 2005-03-10 O'brien John P. Peptide-based diblock and triblock dispersants and diblock polymers
US7807141B2 (en) * 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
EP1663118A4 (en) 2003-09-08 2008-10-15 Du Pont HAIR CARE AND COLORANTS BASED ON PEPTIDES FOR HAIR, SKIN AND NAILS
ES2375360T3 (es) * 2003-11-06 2012-02-29 Danisco Us Inc. Péptidos soportados y de unión a vegf para tratar enfermedades de la piel.
US9062392B2 (en) * 2003-12-30 2015-06-23 Intel Corporation Methods for isolating a peptide methods for identifying a peptide
US20070196305A1 (en) * 2005-03-01 2007-08-23 Hong Wang Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
CN101278051B (zh) * 2005-05-05 2011-10-05 金克克国际有限公司 个人护理组合物及其使用方法
US20060286047A1 (en) * 2005-06-21 2006-12-21 Lowe David J Methods for determining the sequence of a peptide motif having affinity for a substrate
US20070065387A1 (en) * 2005-09-16 2007-03-22 Beck William A Method for enhancing the effect of particulate benefit agents
US7736633B2 (en) 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US8318659B2 (en) 2005-11-15 2012-11-27 E I Du Pont De Nemours And Company Peptide-based organic sunscreens
US7709601B2 (en) * 2005-12-15 2010-05-04 E. I. Du Pont De Nemours And Company Nylon binding peptides and methods of use
US7632919B2 (en) * 2005-12-15 2009-12-15 E.I. Du Pont De Nemours And Company Polystyrene binding peptides and methods of use
US7858581B2 (en) * 2005-12-15 2010-12-28 E. I. Du Pont De Nemours And Company PMMA binding peptides and methods of use
US7928076B2 (en) * 2005-12-15 2011-04-19 E. I. Du Pont De Nemours And Company Polypropylene binding peptides and methods of use
US7906617B2 (en) 2005-12-15 2011-03-15 E. I. Du Pont De Nemours And Company Polyethylene binding peptides and methods of use
US7700716B2 (en) * 2005-12-15 2010-04-20 E. I. Du Pont De Nemours And Company Polytetrafluoroethylene binding peptides and methods of use
WO2007109299A2 (en) * 2006-03-21 2007-09-27 Duke University Peptide
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
DE102006030028A1 (de) * 2006-06-29 2008-02-14 Forschungszentrum Jülich GmbH Verfahren zum Auffinden von spezifisch an einen Köder bindende Moleküle, sowie spezifisch an einen Köder bindende Moleküle und deren Verwendung
US20080280810A1 (en) * 2006-10-30 2008-11-13 O'brien John P Peptides having affinity for body surfaces
US20080175798A1 (en) * 2006-12-11 2008-07-24 Beck William A Peptide-based hair protectants
US7951559B2 (en) 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US7754680B2 (en) 2007-07-26 2010-07-13 E. I. Du Pont De Nemours And Company Peptides for binding calcium carbonates and methods of use
US20090142283A1 (en) * 2007-11-30 2009-06-04 E. I. Du Pont De Nemours And Company Peptide-based antidandruff reagents
US7998702B2 (en) * 2008-09-17 2011-08-16 E. I. Du Pont De Nemours And Company Mutant arabinose promoter for inducible gene expression
JP5740308B2 (ja) 2008-10-15 2015-06-24 ダニスコ・ユーエス・インク 修飾変異ボウマンブリックプロテアーゼインヒビター
US7772181B2 (en) * 2008-10-15 2010-08-10 Danisco Us Inc. Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
US7803902B2 (en) * 2008-10-15 2010-09-28 Danisco Us Inc. Modified variant bowman birk protease inhibitors
US8697654B2 (en) 2008-12-18 2014-04-15 E I Du Pont De Nemours And Company Peptide linkers for effective multivalent peptide binding
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US7915011B2 (en) * 2009-03-05 2011-03-29 E.I. Du Pont De Nemours And Company Host cell modifications that improve peptide production and downstream processing
CA2758049A1 (en) 2009-03-30 2010-10-14 E.I. Du Pont De Nemours And Company Peptide-based systems for delivery of cosmetic agents
WO2010114638A1 (en) 2009-03-30 2010-10-07 E. I. Du Pont De Nemours And Company Peptide-based tooth whitening reagents
US20100310495A1 (en) * 2009-06-08 2010-12-09 E. I. Du Pont De Nemours And Company Peptides having affinity for poly (benzyl methacrylate-co-methacrylic acid) potassium salt copolymers and methods of use
WO2012134416A2 (en) * 2009-11-18 2012-10-04 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Peptide ligands
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US8663616B2 (en) 2010-12-20 2014-03-04 E I Du Pont De Nemours And Company Enzymatic peracid generation for use in oral care products
KR20140114269A (ko) 2010-12-20 2014-09-26 이 아이 듀폰 디 네모아 앤드 캄파니 표적화된 과가수분해효소
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
US9062312B2 (en) 2011-06-21 2015-06-23 Danisco Us Inc. Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications
WO2014179363A1 (en) 2013-04-29 2014-11-06 Adimab, Llc Polyspecificity reagents, methods for their preparation and use
WO2017115853A1 (ja) * 2015-12-28 2017-07-06 出光興産株式会社 ペプチドタグおよびそれを含むタグ付加タンパク質
CN110453292B (zh) * 2019-06-28 2021-06-29 浙江大学 一种利用噬菌体抗体库高效筛选纤维蛋白原的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
US3929676A (en) * 1974-08-02 1975-12-30 Int Flavors & Fragrances Inc Bicyclic fragrance materials and processes therefor
US4760025A (en) * 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800197A (en) * 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5011681A (en) * 1989-10-11 1991-04-30 Richardson-Vicks, Inc. Facial cleansing compositions
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
DK0600866T3 (da) 1990-06-01 1998-03-09 Chiron Corp Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler
EP0533838B1 (en) * 1990-06-11 1997-12-03 NeXstar Pharmaceuticals, Inc. Nucleic acid ligands
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5292646A (en) * 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5733731A (en) * 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5677136A (en) * 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US6341256B1 (en) * 1995-03-31 2002-01-22 Curagen Corporation Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
US5609826A (en) 1995-04-17 1997-03-11 Ontogen Corporation Methods and apparatus for the generation of chemical libraries
US6475806B1 (en) 1995-06-07 2002-11-05 Praecis Pharmaceuticals, Inc. Anchor libraries and identification of peptide binding sequences
ES2200084T3 (es) 1995-12-18 2004-03-01 Praecis Pharmaceuticals Incorporated Metodos para identificar compuestos que se unen a una diana.
AU2537397A (en) 1996-03-22 1997-10-10 Ontogen Corporation Methods for spatially-dispersed positionally-encoded combinatorial library synthesis
DK0985032T4 (da) 1997-05-28 2009-08-31 Crescendo Biolog Ltd Ribosom-komplekser som selektionspartikler til in vitro fremvisning og evolution af proteiner
GB9716094D0 (en) * 1997-07-30 1997-10-01 Univ Glasgow Mehods for screening bacteriophage libraries
US6639051B2 (en) * 1997-10-20 2003-10-28 Curis, Inc. Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
GB9805793D0 (en) * 1998-03-18 1998-05-13 Glaxo Group Ltd Sodium ion channels
US6861227B2 (en) * 1998-03-19 2005-03-01 Human Genome Sciences, Inc. Antibodies to cytokine receptor common gamma chain like
US6201104B1 (en) 1998-12-04 2001-03-13 Entremed, Inc. Angiogenesis—inhibiting protein binding peptides and proteins and methods of use
US20020098524A1 (en) 2000-04-14 2002-07-25 Murray Christopher J. Methods for selective targeting

Also Published As

Publication number Publication date
US20020098524A1 (en) 2002-07-25
EP1360500B1 (en) 2010-01-13
AU2001257012A1 (en) 2001-10-30
ES2338097T3 (es) 2010-05-04
DE60141088D1 (de) 2010-03-04
US20090093393A1 (en) 2009-04-09
PT1360500E (pt) 2010-04-19
JP2012002818A (ja) 2012-01-05
JP2004518403A (ja) 2004-06-24
ATE455304T1 (de) 2010-01-15
EP1360500A2 (en) 2003-11-12
JP4966470B2 (ja) 2012-07-04
CA2405715A1 (en) 2001-10-25
JP5689764B2 (ja) 2015-03-25
WO2001079479A3 (en) 2003-08-21
DK1360500T3 (da) 2010-05-25
US20130102757A1 (en) 2013-04-25
WO2001079479A2 (en) 2001-10-25
US8779091B2 (en) 2014-07-15
CA2405715C (en) 2011-11-15
US8318640B2 (en) 2012-11-27
US20050112692A1 (en) 2005-05-26
US20140342930A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
CY1109876T1 (el) Μεθοδοι για εκλεκτικη στοχευση
DE69632333D1 (de) Monoklonaler antikörper br110 und dessen anwendung
WO2001069507A3 (en) Proteomics database
CA2263883A1 (en) Kuz, a novel family of metalloproteases
CA2430234A1 (en) An extended tethering approach for rapid identification of ligands
DK1015585T3 (da) TIE ligandhomologer
AU1406195A (en) Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
DK0724456T3 (da) CD40-Antistoffer
PL340449A1 (en) Highly efficient method of functionally classifying proteins identified by gnomic techniques
WO2000075364A3 (en) Nmr rapid identification of bi-ligand drug candidates
WO2002039949A3 (en) Platelet/leukocyte interaction assay and reagent therefor
DE60035434D1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
DE69628194D1 (de) Verfahren zum nachweis von verbindungen die bestimmte zielmoleküle binden
DE69921731D1 (de) Partikelfalle für einen Dieselmotor
DE60332115D1 (de) Verfahren zur identifizierung einzelner aktiver einheiten aus komplexen gemischen
WO2005019431A3 (en) Selective inhibition of toll-like receptor-2
WO2000062074A8 (en) Use of 13c-nmr to detect binding
WO2000075657A3 (de) Screening von target-ligand-wechselwirkungen
WO2001064605A3 (en) Generation and screening of a dynamic combinatorial library
WO2002057792A3 (en) Affinity selection-based screening of hydrophobic proteins
WO2002094194A3 (en) Compositions and methods for inhibiting metastasis
AU2001268944A1 (en) Method for determining the quantity of ligands that are bound to target molecules
WO2002059715A8 (en) Prediction of functional and structural properties of polypeptides
ATE385573T1 (de) Verfahren zum identifizieren von liganden der rna-polymerase sigma 70 untereinheit
DE50001815D1 (de) Beschleuniger für die phosphatierung von metalloberfächen